Have your own idea? Try our Stock Screener
U.S. Biotech Industry Analysis
UpdatedAug 26, 2025
DataAggregated Company Financials
Companies549
- 7D-1.6%
- 3M8.7%
- 1Y-10.3%
- YTD4.0%
Over the last 7 days, the Biotech industry has dropped 1.6%, driven by Gilead Sciences declining 3.3%. However, the industry is down 10% over the past year. Earnings are forecast to grow by 26% annually.
Industry Valuation and Performance
Has the U.S. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 26 Aug 2025 | US$1.1t | US$163.6b | -US$18,607,464,334.90 | 15.2x | -57.7x | 6.6x |
| Thu, 24 Jul 2025 | US$979.1b | US$155.2b | -US$23,256,073,043.15 | 17x | -42.1x | 6.3x |
| Sat, 21 Jun 2025 | US$930.4b | US$155.9b | -US$23,931,619,289.37 | 16.8x | -38.9x | 6x |
| Mon, 19 May 2025 | US$895.2b | US$155.9b | -US$24,392,718,921.60 | 16.3x | -36.7x | 5.7x |
| Wed, 16 Apr 2025 | US$764.9b | US$119.2b | -US$36,605,024,519.56 | 20.2x | -20.9x | 6.4x |
| Fri, 14 Mar 2025 | US$841.0b | US$118.5b | -US$37,519,343,472.27 | 17.8x | -22.4x | 7.1x |
| Sun, 09 Feb 2025 | US$840.3b | US$117.3b | -US$30,891,273,158.04 | 17.2x | -27.2x | 7.2x |
| Tue, 07 Jan 2025 | US$968.2b | US$149.6b | -US$26,363,916,330.88 | 16.7x | -36.7x | 6.5x |
| Thu, 05 Dec 2024 | US$1.0t | US$150.0b | -US$26,559,447,157.66 | 17.4x | -38.6x | 6.8x |
| Sat, 02 Nov 2024 | US$1.1t | US$147.4b | -US$30,526,626,860.52 | 17.5x | -34.7x | 7.2x |
| Mon, 30 Sep 2024 | US$893.6b | US$113.2b | -US$36,006,680,210.71 | 21.3x | -24.8x | 7.9x |
| Wed, 28 Aug 2024 | US$912.3b | US$113.2b | -US$35,873,175,029.80 | 23.7x | -25.4x | 8.1x |
| Fri, 26 Jul 2024 | US$1.2t | US$164.3b | -US$28,279,434,472.09 | 28.4x | -42.8x | 7.4x |
| Sun, 23 Jun 2024 | US$1.2t | US$164.4b | -US$27,942,490,934.12 | 28.1x | -41.4x | 7x |
| Tue, 21 May 2024 | US$1.1t | US$164.6b | -US$26,833,016,716.77 | 24.2x | -42.8x | 7x |
| Thu, 18 Apr 2024 | US$1.1t | US$164.2b | -US$23,335,767,618.82 | 20.4x | -46.2x | 6.6x |
| Sat, 16 Mar 2024 | US$1.2t | US$167.4b | -US$22,091,319,843.29 | 13.9x | -53.3x | 7x |
| Mon, 12 Feb 2024 | US$1.2t | US$169.3b | -US$26,263,046,791.87 | 19.8x | -44.2x | 6.9x |
| Wed, 10 Jan 2024 | US$1.4t | US$204.8b | -US$22,502,246,114.00 | 20.4x | -64.2x | 7.1x |
| Fri, 08 Dec 2023 | US$1.3t | US$204.6b | -US$22,051,399,456.00 | 19.3x | -58.1x | 6.3x |
| Sun, 05 Nov 2023 | US$1.2t | US$206.7b | -US$20,535,513,316.00 | 18.8x | -60.4x | 6x |
| Tue, 03 Oct 2023 | US$1.3t | US$207.3b | -US$13,085,561,707.00 | 16.8x | -96x | 6.1x |
| Thu, 31 Aug 2023 | US$1.3t | US$207.7b | -US$12,462,393,654.00 | 17.6x | -103.8x | 6.2x |
| Sat, 29 Jul 2023 | US$1.1t | US$186.0b | -US$15,177,418,533.00 | 14.7x | -74.9x | 6.1x |
| Mon, 26 Jun 2023 | US$1.1t | US$186.2b | -US$16,162,116,001.00 | 13.6x | -70.3x | 6.1x |
| Wed, 24 May 2023 | US$1.2t | US$186.1b | -US$15,836,040,128.00 | 12.9x | -73.2x | 6.2x |
| Fri, 21 Apr 2023 | US$1.2t | US$198.4b | -US$3,235,324,680.00 | 13.6x | -364.2x | 5.9x |
| Sun, 19 Mar 2023 | US$1.1t | US$199.2b | -US$3,885,938,113.00 | 13.2x | -287.6x | 5.6x |
| Tue, 14 Feb 2023 | US$1.2t | US$202.8b | -US$239,371,196.00 | 16.5x | -4869.1x | 5.7x |
| Thu, 12 Jan 2023 | US$1.2t | US$203.6b | US$1.7b | 14.3x | 687.1x | 5.7x |
| Sat, 10 Dec 2022 | US$1.1t | US$202.7b | US$1.4b | 14.6x | 811.3x | 5.6x |
| Mon, 07 Nov 2022 | US$1.1t | US$204.3b | US$3.8b | 13.4x | 285.1x | 5.3x |
| Wed, 05 Oct 2022 | US$1.1t | US$206.5b | US$5.6b | 15.6x | 189.7x | 5.2x |
| Fri, 02 Sep 2022 | US$1.1t | US$206.1b | US$7.2b | 15.3x | 147.2x | 5.1x |
Price to Earnings Ratio
147.2x
Current Industry PE
- Investors are relatively neutral on the American Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 6.4x.
Past Earnings Growth
- Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 7.4% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the U.S. Healthcare industry?
| US Market | 0.19% | |
| Healthcare | -0.34% | |
| Biotech | -1.63% | |
| Biotech | -1.63% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ABBV AbbVie | US$207.55 | 0.7% +US$2.4b | 5.9% | PE98.5x | |
| CAI Caris Life Sciences | US$38.48 | 7.0% +US$711.5m | n/a | PS20.3x | |
| MDGL Madrigal Pharmaceuticals | US$412.23 | 5.3% +US$463.6m | 61.2% | PS17.8x | |
| MENS Jyong Biotech | US$47.00 | 13.3% +US$408.3m | n/a | PE-1155.7x | |
| HALO Halozyme Therapeutics | US$72.21 | 4.7% +US$380.1m | 16.2% | PE15.2x |
